SCHEMBL10737709

SCHEMBL10737709

COc1ccc(OC)c(-c2nc3cnncc3[nH]2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 3/20 0.48
▸ KDM4E B2RXH2 4/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ AMY1A P0DUB6 6/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ PDE2A O00408 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10734755 0.89 PDE2A (0.57) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL10740337 0.84 TOP1 (0.41) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL7281035 0.84 PDE5A (0.55) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL10739533 0.83 MGAM (0.57) KDM4ESMN1; SMN2HSD17B10AMY1AALDH1A1
Hydrochloric Acid SCHEMBL10844959 0.83 PDE5A (0.56) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
Hydrochloric Acid SCHEMBL7272791 0.83 PDE5A (0.56) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL10743332 0.83 PDE5A (0.45) PDE5AKDM4EAMY1AALDH1A1HPGD
SCHEMBL10742077 0.82 AMY1A (0.48) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL15643913 0.82 SMN1; SMN2 (0.64) PDE5AKDM4ESMN1; SMN2HSD17B10HTT
SCHEMBL10734339 0.81 PDE5A (0.70) PDE5AKDM4ESMN1; SMN2AMY1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback